New York State Common Retirement Fund’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15
Closed -$1K 3405
2022
Q2
$1K Sell
15
-1,270
-99% -$59.3K ﹤0.01% 3388
2022
Q1
$80K Hold
1,285
﹤0.01% 3073
2021
Q4
$163K Sell
1,285
-4
-0.3% -$653 ﹤0.01% 2947
2021
Q3
$257K Sell
1,289
-312
-19% -$74.4K ﹤0.01% 2809
2021
Q2
$424K Buy
1,601
+476
+42% +$147K ﹤0.01% 2691
2021
Q1
$393K Buy
1,125
+185
+20% +$79K ﹤0.01% 2552
2020
Q4
$481K Buy
940
+315
+50% +$126K ﹤0.01% 2378
2020
Q3
$164K Hold
625
﹤0.01% 2732
2020
Q2
$342K Buy
+625
New +$281K ﹤0.01% 2407

Other funds holding PASG

New York State Common Retirement Fund's PASG Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Passage Bio (PASG) in Q3 2022, closing a stake of 15 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in PASG in Q2 2020 and held it in 9 quarters. The position peaked at $481K in Q4 2020. 75 funds tracked by Wall St. Rank hold PASG as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Passage Bio position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 15 Passage Bio shares in Q3 2022, an estimated $1K.
  • New York State Common Retirement Fund first reported a position in Passage Bio in Q2 2020 and held it in 9 quarters.
  • New York State Common Retirement Fund's Passage Bio position peaked at $481K in Q4 2020.
  • 75 funds tracked by Wall St. Rank held Passage Bio as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.